Ho-Yong Park

发表

Novel modular endo-β-1,4-xylanase with transglycosylation activity from Cellulosimicrobium sp. strain HY-13 that is homologous to inverting GH family 6 enzymes.

Y. Rhee, Hyo Jeong Kim, K. Son, 2012, Bioresource technology.

A highly active endo-β-1,4-mannanase produced by Cellulosimicrobium sp. strain HY-13, a hemicellulolytic bacterium in the gut of Eisenia fetida.

Y. Rhee, K. Son, Hyun Ju Lee, 2011, Enzyme and microbial technology.

Cloning and characterization of a modular GH5 β-1,4-mannanase with high specific activity from the fibrolytic bacterium Cellulosimicrobium sp. strain HY-13.

Y. Rhee, K. Son, Hyun Ju Lee, 2011, Bioresource technology.

Novel intracellular GH10 xylanase from Cohnella laeviribosi HY-21: biocatalytic properties and alterations of substrate specificities by site-directed mutagenesis of Trp residues.

Y. Rhee, K. Son, K. Bae, 2010, Bioresource technology.

Human ACAT-1 and -2 inhibitory activities of saucerneol B, manassantin A and B isolated from Saururus chinensis.

K. Bae, Hyoung‐Chin Kim, Kyung-Hyun Cho, 2004, Bioorganic & medicinal chemistry letters.

Development of a novel denture care agent with highly active enzyme, arazyme

S. Bae, Jong-hoon Kim, Dong-Ha Shin, 2021, BMC oral health.

Novel Anti-Fungal d-Laminaripentaose-Releasing Endo-β-1,3-glucanase with a RICIN-like Domain from Cellulosimicrobium funkei HY-13

K. Son, Do Young Kim, Dong-Ha Shin, 2021, Biomolecules.

Phase II study of irinotecan, 5-fluorouracil, and leucovorin in relapsed or metastatic colorectal cancer as first-line therapy.

M. Ahn, Y. Won, Junghye Choi, 2004, Cancer research and treatment : official journal of Korean Cancer Association.

A culture-based study of the bacterial communities within the guts of nine longicorn beetle species and their exo-enzyme producing properties for degrading xylan and pectin.

K. Bae, Doo-Sang Park, H. Oh, 2007, Journal of microbiology.

HER-2/neu Protein Expression in Canine Mammary Adenocarcinoma

K. Jeong, Hai-Jie Yang, S. Do, 2008 .

Isotrifoliol inhibits pro‐inflammatory mediators by suppression of TLR/NF‐&kgr;B and TLR/MAPK signaling in LPS‐induced RAW264.7 cells☆

K. Park, Jeong‐Hyun Yoon, Ho-Yong Park, 2017, International immunopharmacology.